Literature DB >> 6668554

Pharmacokinetics of ibuprofen in man--III: Plasma protein binding.

G F Lockwood, K S Albert, G J Szpunar, J G Wagner.   

Abstract

Plasma protein binding of ibuprofen was measured by equilibrium dialysis on 406 plasma samples collected from 15 normal volunteers following doses of 400, 800, and 1200 mg of ibuprofen as tablets (N = 102, 100, 104, respectively) and 420 mg as an aqueous solution (N = 100). Individual subject bound concentration at dialysis equilibrium (Cbd) vs. free concentration at dialysis equilibrium (Cfd) were well fitted via computer to the Scatchard equation with one class of binding sites. The binding capacity averaged 1231 microM (range 848-1658 microM), and the association constant averaged 1.76 X 10(5) M-1 (range 1.15 X 10(5) to 2.73 X 10(5) M-1). Distributional analysis was performed on the free fraction (fd) and bound/free ratios (Cbd/Cfd = 1/fd-1) at dialysis equilibrium for each treatment. Using pooled data of all four treatments, distributional analysis was also performed on the free fractions (f) and bound/free ratios (Cb/Cf = 1/f-1) corresponding to the plasma drug concentrations in blood as it was withdrawn from the subjects. The bound/free ratios were normally distributed, whereas the distributions of the free fractions were skewed towards higher values.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6668554     DOI: 10.1007/bf01062206

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  11 in total

1.  Statistical estimations in enzyme kinetics.

Authors:  G N WILKINSON
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

2.  Quantitative pooling of Michaelis-Menten equations in models with parallel metabolite formation paths.

Authors:  A J Sedman; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1974-04

3.  Plasma volume changes as a result of equilibrium dialysis.

Authors:  G F Lockwood; J G Wagner
Journal:  J Pharm Pharmacol       Date:  1983-06       Impact factor: 3.765

4.  Binding of nonsteroidal anti-inflammatory agents to proteins--I. Ibuprofen-serum albumin interaction.

Authors:  J B Whitlam; M J Crooks; K F Brown; P V Pedersen
Journal:  Biochem Pharmacol       Date:  1979-03-01       Impact factor: 5.858

5.  The binding sites on human serum albumin for some nonsteroidal antiinflammatory drugs.

Authors:  A Kober; I Sjöholm
Journal:  Mol Pharmacol       Date:  1980-11       Impact factor: 4.436

6.  Protein binding of some non-steroidal anti-inflammatory drugs in rheumatoid arthritis.

Authors:  S Wanwimolruk; D J Birkett; P M Brooks
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

7.  The metabolism of ibuprofen.

Authors:  R F Mills; S S Adams; E E Cliffe; W Dickinson; J S Nicholson
Journal:  Xenobiotica       Date:  1973-09       Impact factor: 1.908

8.  Ultrafiltration in serum protein binding determinations.

Authors:  J B Whitlam; K F Brown
Journal:  J Pharm Sci       Date:  1981-02       Impact factor: 3.534

9.  High-performance liquid chromatographic determination of ibuprofen and its major metabolites in biological fluids.

Authors:  G F Lockwood; J G Wagner
Journal:  J Chromatogr       Date:  1982-11-12

10.  Pharmacokinetics of ibuprofen in man. I. Free and total area/dose relationships.

Authors:  G F Lockwood; K S Albert; W R Gillespie; G G Bole; T M Harkcom; G J Szpunar; J G Wagner
Journal:  Clin Pharmacol Ther       Date:  1983-07       Impact factor: 6.875

View more
  13 in total

1.  Stereoselective plasma protein binding of ibuprofen enantiomers.

Authors:  A M Evans; R L Nation; L N Sansom; F Bochner; A A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Stereoselective drug disposition: potential for misinterpretation of drug disposition data.

Authors:  A M Evans; R L Nation; L N Sansom; F Bochner; A A Somogyi
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

3.  Pharmacokinetics of ibuprofen in man IV: absorption and disposition.

Authors:  J G Wagner; K S Albert; G J Szpunar; G F Lockwood
Journal:  J Pharmacokinet Biopharm       Date:  1984-08

4.  Intra-uterine pressure and serum ibuprofen: observations after oral administration of 400 mg ibuprofen to a patient with primary dysmenorrhoea.

Authors:  I Milsom; B Andersch
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 5.  Clinical pharmacokinetics of ibuprofen. The first 30 years.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

6.  Stereoselective, competitive, and nonlinear plasma protein binding of ibuprofen enantiomers as determined in vivo in healthy subjects.

Authors:  J K Paliwal; D E Smith; S R Cox; R R Berardi; V A Dunn-Kucharski; G H Elta
Journal:  J Pharmacokinet Biopharm       Date:  1993-04

7.  Population pharmacokinetics of high dose ibuprofen in cystic fibrosis.

Authors:  I Arranz; A Martín-Suárez; J M Lanao; F Mora; C Vázquez; A Escribano; M Juste; J Mercader; E Ripoll
Journal:  Arch Dis Child       Date:  2003-12       Impact factor: 3.791

8.  Stereoselective disposition of ibuprofen enantiomers in the isolated perfused rat kidney.

Authors:  H Y Ahn; F Jamali; S R Cox; D Kittayanond; D E Smith
Journal:  Pharm Res       Date:  1991-12       Impact factor: 4.200

Review 9.  Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs.

Authors:  J H Lin; D M Cocchetto; D E Duggan
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

Review 10.  Pharmacokinetics of Ibuprofen in children with cystic fibrosis.

Authors:  Emily E Han; Paul M Beringer; Stan G Louie; Mark A Gill; Bertrand J Shapiro
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.